PART I Item 1. B usiness References to Plus Therapeutics, the Company, we, us and our refer to Plus Therapeutics, Inc. References to Notes refer to the Notes to Financial Statements included herein (refer to Item 8). General Plus Therapeutics is a U.S. healthcare company developing and commercializing precision diagnostics and targeted radiopharmaceuticals for central nervous system (CNS) cancers. CNSide Diagnostics, LLC (CNSide Diagnostics) is our wholly owned subsidiary that develops and comme...
Q2 FY2026 — expected 2026-08-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001193125-26-104258 | EDGAR | 87K words |
| 2025-03-31 | 2024-12-31 | 0000950170-25-047698 | EDGAR | — |
| 2024-03-05 | 2023-12-31 | 0000950170-24-025851 | EDGAR | — |
| 2023-02-23 | 2022-12-31 | 0000950170-23-004099 | EDGAR | — |
| 2022-02-24 | 2021-12-31 | 0001564590-22-006708 | EDGAR | — |
| 2021-02-22 | 2020-12-31 | 0001564590-21-007165 | EDGAR | — |
| 2020-03-30 | 2019-12-31 | 0001564590-20-014165 | EDGAR | — |
| 2019-03-29 | 2018-12-31 | 0001564590-19-010018 | EDGAR | — |
| 2018-03-09 | 2017-12-31 | 0001564590-18-005136 | EDGAR | — |
| 2017-03-24 | 2016-12-31 | 0001564590-17-005251 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-10-30 | 2025-09-30 | 0001193125-25-258596 | EDGAR | 37K words |
| 2025-08-14 | 2025-06-30 | 0000950170-25-108874 | EDGAR | — |
| 2025-05-30 | 2025-03-31 | 0000950170-25-079738 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0000950170-24-127014 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0000950170-24-097091 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0000950170-24-060395 | EDGAR | — |
| 2023-10-31 | 2023-09-30 | 0000950170-23-056844 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0000950170-23-042363 | EDGAR | — |
| 2023-04-20 | 2023-03-31 | 0000950170-23-013671 | EDGAR | — |
| 2022-10-20 | 2022-09-30 | 0000950170-22-019798 | EDGAR | — |
| 2022-07-21 | 2022-06-30 | 0001564590-22-026156 | EDGAR | — |
| 2022-04-21 | 2022-03-31 | 0001564590-22-015075 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-02 | 0001193125-26-140267 | EDGAR | 1K words |
| 2026-03-26 | 0001193125-26-125195 | EDGAR | — |
| 2026-03-12 | 0001193125-26-104291 | EDGAR | — |
| 2026-03-12 | 0001193125-26-104218 | EDGAR | — |
| 2026-02-13 | 0001193125-26-051379 | EDGAR | — |
| 2026-01-22 | 0001193125-26-018675 | EDGAR | — |
| 2026-01-16 | 0001193125-26-015346 | EDGAR | — |
| 2025-11-17 | 0001193125-25-283935 | EDGAR | — |
| 2025-10-30 | 0001193125-25-258568 | EDGAR | — |
| 2025-10-21 | 0001193125-25-244275 | EDGAR | — |
427 total filings indexed. 395 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001095981 |
| Ticker | PSTV |
| Exchange | Nasdaq |
| SIC | 3841: Surgical & Medical Instruments & Apparatus |
| Incorporated | DE |
| Website | https://www.plustherapeutics.com |
| Listed | 2000-11-16 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report